General Information of Drug (ID: DM6NF5F)

Drug Name
NDX-1017
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 1 [1]
Cross-matching ID
PubChem CID
156596374
TTD ID
D0E3CX

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)